Evolving therapies to greatly aid in controlling obesity

RELATED NEWS Laugh your way to good health America offers helping hand to cancer patients in India First HIV gene therapy test is good Nifty BSE | NSE 29/05/12 Are Mutual Funds betting on Nifty?

Although the demand for diverse anti-obesity therapies is growing, the sector is yet to capture increased value through the commercialization of products and research findings.

 

"Moreover, novel drug targets have had minimal impact on the revenues since only two drugs have been approved for long-term usage and others are still under development," notes Prabakar. "However in the future traditional drug-based approaches are necessary to address the needs of a broader market in spite of significant developments in the weight loss market in the form of multivariate treatment options such as surgery and implantable devices, which offer a solution mainly for the significantly obese patients."

 

With this in mind healthcare companies can achieve significant revenues by commercializing new products and offering cost-effective therapies that enable greater weight loss with minimal side effects.

 

Clinical Management of Obesity is part of the Technical Insights - Healthcare Vertical, which also includes research in the following applications/technologies: diet therapies, lifestyle modifications, pharmacotherapy, bariatric surgeries, and medical devices for weight loss. All research included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants. Interviews with the press are available.

 

Technical Insights is an international technology analysis business that produces a variety of technical news alerts, newsletters, and research services.

  

Sourced From: Frost & Sullivan